Clinical trial
A Placebo-controlled, Double-blind, Randomized Trial to Evaluate the Efficacy of ENA-001 in Preventing Postoperative Respiratory Depression
NCT06137638 is registered in ClinicalTrials.gov with Enalare Therapeutics Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Placebo-controlled, Double-blind, Randomized Trial to Evaluate the Efficacy of ENA-001 in Preventing Postoperative Respiratory Depression
- Lead sponsor
- Enalare Therapeutics Inc.
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- December 15, 2026
- Completion date
- July 15, 2027
- Enrollment
- 200 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
respiratory depression